Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00509574 |
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, also known as statins, played an important role in lipid-lowering therapy and reduction of cardiovascular risks. However, it has been observed that the response to statin therapy varies from patient to patient, and gene polymorphism could have contributed to the variation.
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy |
blood samples are obtained for genomic DNA extraction.
Estimated Enrollment: | 200 |
Study Start Date: | March 2007 |
Estimated Study Completion Date: | December 2008 |
Hyperlipidemic patients are retrospectively screened from 2006/1/1 to 2006/12/31. The patient is included if he or she had been receiving atorvastatin or rosuvastatin for at least 3 months and did not receive other lipid-lowering medications 4 weeks before starting atorvastatin or rosuvastatin. Genomic DNA was collected from the blood sample of each patient using genomic DNA purification kit. The single nucleotide polymorphisms (SNPs) were determined afterward.
The correlation between response of statin therapy, defined as changes in lipid profiles including triglyceride, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol, and SNPs examined.
Ages Eligible for Study: | 21 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Hyperlipidemic patients meeting the criteria of NCEP ATPIII for drug treatment at internal medicine clinic of National Taiwan University Hospital.
Inclusion Criteria:
Exclusion Criteria:
Contact: Tzung-Dau Wang, MD, PhD | 886-2-2312-3456 ext 5632 | tdwang@ntu.edu.tw |
Taiwan | |
National Taiwan University Hospital | Recruiting |
Taipei, Taiwan |
Principal Investigator: | Tzung-Dau Wang, MD, PhD | Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital |
Responsible Party: | National Taiwan University Hospital ( Tzung-Dau Wang, MD, PhD ) |
Study ID Numbers: | 200702006M |
Study First Received: | July 29, 2007 |
Last Updated: | November 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00509574 |
Health Authority: | Taiwan: Department of Health |
Single Nucleotide Polymorphism statins hyperlipidemia |
Hyperlipidemias |